Menu ×


Thoracic Vascular Stent Grafts Market Analysis by Type (Plastic Thoracic Vascular Stent Grafts, and Metal Thoracic Vascular Stent Grafts); and by End-User (Hospitals, Ambulatory Surgical Centers, Medical Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • July 4th, 2022: Terumo Corporation has launched the Thoraflex Hybrid Device for the treatment of complex aortic arch disease. The single-use device is comprised of a Gelweave polyester graft coupled to a Nitinol self-expanding stent.

  • January 27th, 2021: Lifetech Scientific (Shenzhen) Co., Ltd. has attained a formal written notice from the National Medical Products Administration (“NMPA”) authorizing the admission of the Artery Stent Graft System (chimney technology) into the NMPA Special Examination and Approval Procedure for Innovative Medical Services. This is the world's first stent graft system engineered specifically for "chimney technology", a mainstream technology for treating aortic dissection lesions.

Global Thoracic Vascular Stent Grafts Market Size, Forecast, and Trend Highlights Over 2022 - 2031

Thoracic Vascular Stent Grafts Market Region Table

The global thoracic vascular stent grafts market is estimated to garner a notable revenue by the end of 2031 by growing at a CAGR of ~5% over the forecast period, i.e., 2022 – 2031. Further, the market generated a significant revenue in the year 2021. The growth of the market is primarily attributed to increasing prevalence of cardiovascular diseases, changing eating habits, and changing lifestyle. According to the data provided by the World Health Organization (WHO), every year, approximately 17.9 million individuals globally die from CVDs, accounting for 32% of all deaths.

Thoracic Vascular Stent Grafts Market overview

Get more information on this report: Request Sample PDF

Thoracic vascular stent grafts are a surgical procedure used to repair thoracic vascular aneurysms. A thoracic aneurysm is a thickening in the main heart artery that increases the aorta's diameter by more than 151%. These grafts come into play when such condition causes rupturing or tearing and later internal bleeding. Instead of traditional surgery to repair an aortic aneurysm, this procedure is also implied to get optimum results. It is a minimally invasive surgery treatment option in the vascular stent grafts sector that is delivering promising results. Rising cases of aneurysm is one such factor which leads towards the increasing demand of thoracic vascular stent grafts over the forecast period. For instance, aortic aneurysm-related mortality is estimated to cause 160,000–232,000 deaths annually with a survival rate of less than 20%.

Global Thoracic Vascular Stent Grafts Market: Growth Drivers and Challenges

Growth Drivers

  • Increasing Geriatric Population – Old age brings so many health issues to the aged people. People have slow recovery rate in their old age, therefore elderly people face numerous variety of health problems that have a significant influence on their overall quality of life. As per the World Health Organization, in 2019, there were approximately 1 billion people aged 60 and over. This number is expected to increase nearly 1.4 billion by 2030 and 2.1 billion by 2050.

  • Growing Cases of Hypertension – For instance, since 1990, the number of people with hypertension has doubled to 1.28 billion by 2021. Furthermore, more than 700 million people worldwide are currently coping with untreated hypertension.

  • Increasing Consumption of Tobacco – As per the data, every year, tobacco kills over 8 million people. More than 7 million of such deaths are caused by direct tobacco usage, whereas approximately 1.2 million are caused by nonsmokers being exposed to second-hand smoke.

  • Upsurge in Fast Food Consumption – For instance, approximately 51 million individuals in the United States prefer to eat fast food on any given day. Whereas, nearly 22% individuals consume fast food as a minimum twice a week.

  • Rising Per Capita Income – According to the World Bank, compared to 2019, the global annual per capita income increased by 4.8% in 2021, while it only increased by 1.5% in 2019.


  • High Cost of Thoracic Vascular Stent Grafts Treatment
  • Growing Acceptance of Balloon Angioplasty
  • Hurdles Associated with Thoracic Stent Grafts

The global thoracic vascular stent grafts market is segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, medical centers, and others, out of which the hospitals segment is estimated to radically grow over the forecast period owing to the mounting number of patients visits to be diagnosed in hospitals, increasing incidences of CVDs, availability of better medical reimbursement, and globally increasing healthcare expenditure. As per the World Bank, global healthcare expenditure expanded to 9.83% in 2019 from 9.7% in 2018.

Major Macro-Economic Indicators Impacting the Market Growth

Thoracic Vascular Stent Grafts Market Region

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Thoracic Vascular Stent Grafts Market Regional Synopsis

Regionally, the global thoracic vascular stent grafts market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2031 backed by the rise in aged population, technological developments, and high prevalence of cardiovascular diseases (CVDs) in the region. According to the Centers for disease Control and Prevention, in the United States, heart disease accounted for the deaths of about 697,000 people in 2020. Besides this, nearly 20.1 million adults aged 20 and above are influenced by coronary artery disease.

Thoracic Vascular Stent Grafts Market Regional Synopsis

Get more information on this report: Request Sample PDF

The global thoracic vascular stent grafts market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global thoracic vascular stent grafts market includes the following segments:

By Type

  • Plastic Thoracic Vascular Stent Grafts
  • Metal Thoracic Vascular Stent Grafts

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Medical Centers
  • Others

Top Featured Companies Dominating the Global Thoracic Vascular Stent Grafts Market

  • Medtronic plc
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • JOTEC GmbH
  • Cook Group Incorporated
  • Terumo Corporation
  • Cardinal Health, Inc.
  • LeMaitre Vascular, Inc.
  • Merit Medical Systems, Inc.
  • Lombard Medical Ltd
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • Braile Biomédica


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved